| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.6 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.074 | 0.6 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.6 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.7 |